ICD-10-CM 2027 diagnosis code
G13Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
G13 is a header code, so it can't be reported by itself. Choose one of the 4 more specific codes beneath it.Short description: Systemic atrophies aff cnsl in diseases classd elswhr
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About G13
G13 is the ICD-10-CM diagnosis code for systemic atrophies primarily affecting central nervous system in diseases classified elsewhere. It belongs to block G10-G14 (systemic atrophies primarily affecting the central nervous system) and chapter 6 (diseases of the nervous system). It is a header code, so it can't be reported by itself; one of its 4 subcodes must be used instead.
To report this condition, pick the subcode that matches the documentation: G13.0 (neuropathy), G13.1 (disease), G13.2 (myxedema) and G13.8 (elsewhere).
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
Specific codes under G13
- G13.0Paraneoplastic neuromyopathy and neuropathyBillable
- G13.1Other systemic atrophy primarily affecting central nervous system in neoplastic diseaseBillable
- G13.2Systemic atrophy primarily affecting the central nervous system in myxedemaBillable
- G13.8Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhereBillable
Notes that apply from higher levels
Instructions written at a parent level also apply to G13.
Broader instructions also apply from Chapter 6: Diseases of the nervous system.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about G13
Is G13 billable?
- No. G13 is a header code. Report one of its more specific subcodes instead.